Schizophrenia Research
Volume 119, Issue 1 , Page 268 , June 2010

Varenicline induced polydipsia and hyponatremia in a patient with schizophrenia

  • Zahinoor Ismail

      Affiliations

    • Department of Psychiatry, University of Toronto, Toronto, Canada
    • Department of Psychiatry, University of Calgary, Calgary, Canada
    • Corresponding Author InformationCorresponding author. Department of Psychiatry, University of Toronto, Toronto, Canada. Tel.: +1 416 535 8501x2574; fax: +1 416 5831307.
    • ,
  • Jonathan Syms

      Affiliations

    • Centre for Addiction and Mental Health, Toronto, Canada
    • ,
  • Daniel Blumberger

      Affiliations

    • Department of Psychiatry, University of Toronto, Toronto, Canada
    • ,
  • Tony P. George

      Affiliations

    • Department of Psychiatry, University of Toronto, Toronto, Canada

Received 2 December 2009 ,Revised 27 January 2010 ,Accepted 28 January 2010.

References 

  1. Adler LE, Olincy A, et al. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr. Bull. 1998;24(2):189–202
  2. Allon M, Allen HM, et al. Role of cigarette use in hyponatremia in schizophrenic patients. Am. J. Psychiatry. 1990;147(8):1075–1077
  3. de Leon J, Tracy J, et al. Polydipsia and schizophrenia in a psychiatric hospital: a replication study. Schizophr. Res. 2002;57(2–3):293–301
  4. Finch CK, Andrus MR, et al. Nicotine replacement therapy-associated syndrome of inappropriate antidiuretic hormone. South. Med. J. 2004;97(3):322–324
  5. Shutty MS. Cigarette use, drinking and voiding in schizophrenic patients with polydipsia and hyponatremia. Schizophr. Res. 1996;21(3):195–197

PII: S0920-9964(10)00079-4

doi: 10.1016/j.schres.2010.01.027

Schizophrenia Research
Volume 119, Issue 1 , Page 268 , June 2010

Article Tools